These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23024296)

  • 41. Fewer recurrent infections of C. difficile seen with fidaxomicin. This new class of antibiotic--the macrocycles--has a greater sustained response against re-infection than vancomycin.
    Morrow T
    Manag Care; 2011 Jul; 20(7):49-50. PubMed ID: 21848202
    [No Abstract]   [Full Text] [Related]  

  • 42. [Infections with Clostridium difficile following antibiotic therapy].
    Scheppach W
    MMW Fortschr Med; 2009 Oct; 151(40):47-9. PubMed ID: 19927920
    [No Abstract]   [Full Text] [Related]  

  • 43. New developments in chemotherapeutic options for Clostridium difficile colitis.
    Ritter AS; Petri WA
    Curr Opin Infect Dis; 2013 Oct; 26(5):461-70. PubMed ID: 23982237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative susceptibilities to fidaxomicin (OPT-80) of isolates collected at baseline, recurrence, and failure from patients in two phase III trials of fidaxomicin against Clostridium difficile infection.
    Goldstein EJ; Citron DM; Sears P; Babakhani F; Sambol SP; Gerding DN
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5194-9. PubMed ID: 21844318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sustained clinical response as an endpoint in treatment trials of Clostridium difficile-associated diarrhea.
    Johnson S; Gerding DN; Louie TJ; Ruiz NM; Gorbach SL
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4043-5. PubMed ID: 22615287
    [No Abstract]   [Full Text] [Related]  

  • 46. Resolution of recurrent Clostridium difficile-associated diarrhea using staggered antibiotic withdrawal and kefir.
    Bakken JS
    Minn Med; 2009 Jul; 92(7):38-40. PubMed ID: 19708314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clostridium difficile enteritis following total colectomy.
    Yafi FA; Selvasekar CR; Cima RR
    Tech Coloproctol; 2008 Mar; 12(1):73-4. PubMed ID: 18524025
    [No Abstract]   [Full Text] [Related]  

  • 48. Fidaxomicin: in Clostridium difficile infection.
    Duggan ST
    Drugs; 2011 Dec; 71(18):2445-56. PubMed ID: 22141387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
    Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
    Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of fidaxomicin through a nasogastric tube for the treatment of septic shock caused by Clostridium difficile infection in a patient with oral cancer admitted to the Surgical Critical Care Unit.
    Maseda E; Hernandez-Gancedo C; Lopez-Tofiño A; Suarez-de-la Rica A; Garcia-Bujalance S; Gilsanz F
    Rev Esp Quimioter; 2013 Dec; 26(4):375-7. PubMed ID: 24399354
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
    Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treating Clostridium difficile infection.
    Shafran DM; Shafran SD
    CMAJ; 2014 Apr; 186(7):531. PubMed ID: 24344151
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clostridium difficile infections - still a major challenge].
    Strauss R; Neurath MF
    MMW Fortschr Med; 2013 Apr; 155(7):57-9. PubMed ID: 23668179
    [No Abstract]   [Full Text] [Related]  

  • 54. Fidaxomicin: a novel macrolide antibiotic for Clostridium difficile infection.
    Chahine EB; Sucher AJ; Mantei K
    Consult Pharm; 2014 Sep; 29(9):614-24. PubMed ID: 25203410
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fidaxomicin: a review of its use in patients with Clostridium difficile infection.
    Scott LJ
    Drugs; 2013 Oct; 73(15):1733-47. PubMed ID: 24136090
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The approach to recurrent infections with Clostridium difficile].
    Paz Z; Altman A
    Harefuah; 2008 Nov; 147(11):864-5, 942. PubMed ID: 19264004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of rifaximin and vancomycin combination therapy in a patient with refractory Clostridium difficile-associated diarrhea.
    Berman AL
    J Clin Gastroenterol; 2007; 41(10):932-3. PubMed ID: 18090164
    [No Abstract]   [Full Text] [Related]  

  • 58. Successful treatment of severe Clostridium difficile infection by administration of crushed fidaxomicin via a nasogastric tube in a critically ill patient.
    Arends S; Defosse J; Diaz C; Wappler F; Sakka SG
    Int J Infect Dis; 2017 Feb; 55():27-28. PubMed ID: 28027991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frozen encapsulated stool in recurrent Clostridium difficile: exploring the role of pills in the treatment hierarchy of fecal microbiota transplant nonresponders.
    Stollman N; Smith M; Giovanelli A; Mendolia G; Burns L; Didyk E; Burgess J; Noh A; Edelstein C; Alm E; Kassam Z
    Am J Gastroenterol; 2015 Apr; 110(4):600-1. PubMed ID: 25853204
    [No Abstract]   [Full Text] [Related]  

  • 60. Fidaxomicin for the treatment of Clostridium difficile infections.
    Whitman CB; Czosnowski QA
    Ann Pharmacother; 2012 Feb; 46(2):219-28. PubMed ID: 22318930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.